Abstract
The platelet is a component of blood that functions to initiate blood clotting. Abnormal platelet count and function can lead to a life-threatening condition caused by excessive bleeding. At present, platelet supply for transfusion can be obtained only from platelet donation. However, platelets cannot be stored for longer than 7 days, meaning that routine isolation is required to maintain platelet supply for transfusion. To mitigate for potential platelet shortages, several strategies have been proposed to generate platelets ex vivo. By employing both of natural and artificial approaches, several researchers have successfully generated biomaterials with characteristics similar to human-derived platelets. Their reports indicated that the biomaterials could mimic the aggregation of human-isolated platelets, further suggesting the possibility to substitute or complement human-isolated platelets. The current review summarizes the progress in ex vivo platelet production and gives a prospect for the possible approaches to achieving a feasible platelet factory, based on the Good Manufacturing Practice standards.
Similar content being viewed by others
References
Akashi K, Traver D, Miyamoto T, Weissman I (2000) A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404:193–197
Avanzi M, Chen A, He W, Mitchell W (2012) Optimizing megakaryocyte polyploidization by targeting multiple pathways of cytokinesis. Transfusion 52:2406–2413
Avecilla S, Hattori K, Heissig B, Tejada R, Liao F et al (2004) Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med 10:64–71
Bartley T, Bogenberger J, Hunt P, Li Y, Lu H, Martin F, Chang M-S, Samal B, Nichol JL, Swift S, Johnson MJ, Hsu R-Y, Parker VP, Suggs S, Skrine JD, Merewether LA, Clogston C, Hsu E, Hokom MM, Hornkohl A, Choi E, Pangelinan M, Sun Y, Mar V, McNinch J, Simonet L, Jacobsen F, Xie C, Shutter J, Chute H, Basu R, Selander L, Trollinger D, Sieu L, Padilla D, Trail G, Elliott G, Izumi R, Covey T, Crouse J, Garcia A, Xu W, Del Castillo J, Biron J, Cole S, Hu MC-T, Pacifici R, Ponting I, Saris C, Wen D, Yung YP, Lin H, Rosselman RA (1994) Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 77:1117–1124
Beers J, Linask K, Chen J, Siniscalchi L, Lin Y, Zheng W, Rao M, Chen G (2015) A cost-effective and efficient reprogramming platform for large-scale production of integration-free human induced pluripotent stem cells in chemically defined culture. Sci Rep 5. doi:10.1038/srep11319
Bosse R, Singhofer-Wowra M, Rosenthal F, Schulz G (1997) Good manufacturing practice production of human stem cells for somatic cell and gene therapy. Stem Cells 15:275–280
Carter M, Wilson J, Redpath G, Hayes P, Mitchell C (2011) Donor recruitment in the 21st century: challenges and lessons learned in the first decade. Transfus Apheres Sci 45:31–43
Chang Y, Bluteau D, Debili N, Vainchenker W (2007) From hematopoietic stem cells to platelets. J Thromb Haemost 5:318–327
Chen T, Yao C, Chu I, Chuang T, Hsieh T, Hwang S (2009a) Large generation of megakaryocytes from serum-free expanded human CD34+ cells. Biochem Biophys Res Commun 378:112–117
Chen T, Hwang S, Chu I, Hsu S, Hsieh T, Yao C (2009b) Characterization and transplantation of induced megakaryocytes from hematopoietic stem cells for rapid platelet recovery by a two-step serum-free procedure. Exp Hematol 37:1330–1339
Choi E, Nichol J, Hokom M, Hornkohl A, Hunt P (1995) Platelet generated in vitro from proplatelet displaying human megakaryocytes are functional. Blood 85:402–413
Deutsch V, Tomer A (2006) Megakaryocyte development and platelet production. Br J Haematol 134:453–466
Doshi N, Orje J, Molins B, Smith J, Mitragotri S, Ruggeri Z (2012) Platelet mimetic particles for targeting thrombi in flowing blood. Adv Mater 24:3864–3869
Feigal E, Tsokas K, Viswanathan S, Zhang J, Priest C, Pearcee J, Mount N (2014) Proceedings: international regulatory considerations on development pathways for cell therapies. Stem Cells Transl Med 3:879–887
Feng Q, Shabrani N, Thon J, Huo H, Thiel A, Machlus K, Kim K, Brooks J, Li F, Luo C, Kimbrel EA (2014) Scalable generation of universal platelets from human induced pluripotent stem cells. Stem Cell Reports 3:817–831
Fugman D, Witte D, Jones C, Aronow B, Lieberman M (1990) In vitro establishment and characterization of a human megakaryoblastic cell line. Blood 75:1252–1261
Gandhi M, Drachman J, Reems J, Thorning D, Lannutti B (2005) A novel strategy for generating platelet-like fragments from megakaryocytic cell lines and human progenitor cells. Blood Cells Mol Dis 35:70–73
Giammona L, Fuhrken P, Papoutsakis E, Miller W (2006) Nicotinamide (vitamin B3) increases the polyploidisation and proplatelet formation of cultured primary human megakaryocytes. Br J Haematol 135:554–566
Gitz E, Koekman C, van den Heuvel D, Deckmyn H, Akkerman J, Gerritsen H, Urbanus R (2012) Improved platelet survival after cold storage by prevention of glycoprotein Ib alpha clustering in lipid rafts. Haematol Hematol J 97:1873–1881
Greenberg S, Rosenthal D, Greeley T, Tantravahi R, Handin R (1988) Characterization of a new megakaryocytic cell line: the Dami cell. Blood 72:1968–1977
Gresele P (2008) Platelets in hematologic and cardiovascular disorders: a clinical handbook. Cambridge University Press, Cambridge
Hoffbrand A, Moss P, Pettit J (2011) Essential haematology. Wiley, Oxford
Hoffman R, Yang H, Bruno E, Straneva J (1985) Purification and partial characterization of a megakaryocyte colony-stimulating factor from human plasma. J Clin Investig 75:1174–1182
Jiang F, Jia Y, Cohen I (2002) Fibronectin- and protein kinase C-mediated activation of ERK/MAPK are essential for proplateletlike formation. Blood 99:3579–3584
Junt T, Schulze H, Chen Z, Massberg S, Goerge T, Krueger A, Wagner DD, Graf T, Italiano JE Jr, Shivdasani RA, von Andrian UH (2007) Dynamic visualization of thrombopoiesis within bone marrow. Science 317:1767–1770
Kato T, Ogami K, Shimada Y, Iwamatsu A, Sohma Y, Akahori H, Horie K, Kokubo A, Kudo Y, Maeda E, Kobayashi K, Ohashi H, Ozawa T, Inoue H, Kawamura K, Miyazaki H (1995) Purification and characterization of thrombopoietin. J Biochem 118:229–236
Kempner M, Felder R (2002) A review of cell culture automation. J Lab Autom 7:56–62
Komatsu N, Kunitama M, Yamada M, Hagiwara T, Kato T, Miyazaki H, Eguchi M, Yamamoto M, Miura Y (1996) Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO. Blood 87:4552–4560
Konagaya S, Ando T, Yamauchi T, Suemori H, Iwata H (2015) Long-term maintenance of human induced pluripotent stem cells by automated cell culture system. Sci Rep 5: 16647. doi:10.1038/srep16647
Lannutti B, Blake N, Gandhi M, Reems J, Drachman J (2005) Induction of polyploidization in leukemic cell lines and primary bone marrow by Src kinase inhibitor SU6656. Blood 105:3875–3878
Limb J, Song D, Jeon M, Han S, Han G, Jhon G, Bae Y, Kim J (2015) 2-(Trimethylammonium)ethyl (R)-3-methoxy-3-oxo-2-stearamidopropyl phosphate promotes megakaryocytic differentiation of myeloid leukaemia cells and primary human CD34+ haematopoietic stem cells. J Tissue Eng Regen Med 9:435–446
Lok S, Kaushansky K, Holly R, Kuijper J, Loftonday C, Oort P, Grant FJ, Heipel MD, Burkhead SK, Kramer JM, Bell LA, Sprecher CA, Blumberg H, Johnson R, Prunkard D, Ching AFT, Mathewes SL, Bailey MC, Forstrom JW, Buddle MM, Osborn SG, Evans SJ, Sheppard PO, Presnell SR, O'Hara PJ, Hagen FS, Roth GJ, Foster DC (1994) Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 369:565–568
Lordier L, Jalil A, Aurade F, Larbret F, Larghero J, Debili N, Vainchenker W, Chang Y (2008) Megakaryocyte endomitosis is a failure of late cytokinesis related to defects in the contractile ring and Rho/Rock signaling. Blood 112:3164–3174
Lu S, Li F, Yin H, Feng Q, Kimbrel E, Hahm E, Thon J, Wang W, Italiano JE, Cho J, Lanza R (2011) Platelets generated from human embryonic stem cells are functional in vitro and in the microcirculation of living mice. Cell Res 21:530–545
Machlus K, Italiano J (2013) The incredible journey: from megakaryocyte development to platelet formation. J Cell Biol 201:785–796
Matsunaga T, Tanaka I, Kobune M, Kawano Y, Tanaka M, Kuribayashi K, Iyama S, Sato T, Sato Y, Takimoto R, Takayama T, Kato J, Ninomiya T, Hamada H, Niitsu Y (2006) Ex vivo large-scale generation of human platelets from cord blood CD34+ cells. Stem Cells 24:2877–2887
Mattia G, Vulcano F, Milazzo L, Barca A, Macioce G, Giampaolo A, Hassan H (2002) Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release. Blood 99:888–897
Mazur E, Basilico D, Newton J, Cohen J, Charland C, Sohl P, Narendran A (1990) Isolation of large numbers of enriched human megakaryocytes from liquid cultures of normal peripheral blood progenitor cells. Blood 76:1771–1782
Miyazaki R, Ogata H, Iguchi T, Sogo S, Kushida T, Ito T, Inaba M, Ikehara S, Kobayashi Y (2000) Comparative analyses of megakaryocytes derived from cord blood and bone marrow. Br J Haematol 108:602–609
Mostafa S, Miller W, Papoutsakis E (2000) Oxygen tension influences the differentiation, maturation and apoptosis of human megakaryocytes. Br J Haematol 111:879–889
Nachmias V, Yoshida K (1988) The cytoskeleton of the blood platelet: a dynamic structure. Adv Mol Cell Biol 2:29
Nakagawa Y, Nakamura S, Nakajima M, Endo H, Dohda T, Takayama N, Nakauchi H, Arai F, Fukuda T, Eto K (2013) Two differential flows in a bioreactor promoted platelet generation from human pluripotent stem cell-derived megakaryocytes. Exp Hematol 41:742–748
Nakamura S, Takayama N, Hirata S, Seo H, Endo H, Ochi K, Fujita K, Koike T, Harimoto K, Dohda T, Watanabe A, Okita K, Takahashi N, Sawaguchi A, Yamanaka S, Nakauchi H, Nishimura S, Eto K (2014) Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells. Cell Stem Cell 14:535–548
Nishikii H, Eto K, Tamura N, Hattori K, Heissig B, Kanaji T, Sawaguchi A, Goto S, Ware J, Nakauchi H (2008) Metalloproteinase regulation improves in vitro generation of efficacious platelets from mouse embryonic stem cells. J Exp Med 205:1917–1927
Norol F, Vitrat N, Cramer E, Guichard J, Burstein S, Vainchenker W, Debili N (1998) Effects of cytokines on platelet production from blood and marrow CD34+ cells. Blood 91:830–843
Nurhayati R (2015) Promoted megakaryocytic differentiation of megakaryoblastic cell lines for platelet production in vitro. Dissertation, Osaka University
Nurhayati R, Ojima Y, Nomura N, Taya M (2014) Promoted megakaryocytic differentiation of K562 cells through oxidative stress caused by near ultraviolet irradiation. Cell Mol Biol Lett 19:590–600
Nurhayati R, Ojima Y, Taya M (2015) BMS-777607 promotes megakaryocytic differentiation and induces polyploidization in the CHRF-288-11 cells. Hum Cell 28:65–72
Odell T, Jackson C, Friday T, Charsha D (1969) Effect of thrombocytopenia on megakaryocytopoiesis. Br J Haematol 17:91–101
Ohmine S, Dietz A, Deeds M, Hartjes K, Miller D, Thatava T, Sakuma T, Kudva Y, Ikeda Y (2011) Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells. Stem Cell Res Ther 2:46. doi:10.1186/scrt87
Ojima Y, Duncan M, Nurhayati R, Taya M, Miller W (2013) Synergistic effect of hydrogen peroxide on polyploidization during the megakaryocytic differentiation of K562 leukemia cells by PMA. Exp Cell Res 319:2205–2215
Pang L, Weiss M, Poncz M (2005) Megakaryocyte biology and related disorders. J Clin Investig 115:3332–3338
Panuganti S, Schlinker A, Lindholm P, Papoutsakis E, Miller W (2013) Three-stage ex vivo expansion of high-ploidy megakaryocytic cells: toward large-scale platelet production. Tissue Eng Part A 19:998–1014
Pendaries C, Watson S, Spalton J (2007) Methods for genetic modification of megakaryocytes and platelets. Platelets 18:393–408
Pietrzyk-Nivau A, Poirault-Chassac S, Gandrille S, Derkaoui S, Kauskot A, Letourneur D, Le Visage C, Baruch D (2015) Three-dimensional environment sustains hematopoietic stem cell differentiation into platelet-producing megakaryocytes. PLoS One 10. doi:10.1371/journal.pone.0136652
Saito H (1997) Megakaryocytic cell lines. Baillieres Clin Haematol 10:47–63
Schlinker A, Radwanski K, Wegener C, Min K, Miller W (2015) Separation of in vitro-derived megakaryocytes and platelets using spinning-membrane filtration. Biotechnol Bioeng 112:788–800
Schweinfurth N, Hohmann S, Deuschle M, Lederbogen F, Schloss P (2010) Valproic acid and all trans retinoic acid differentially induce megakaryopoiesis and platelet-like particle formation from the megakaryoblastic cell line MEG-01. Platelets 21:648–657
Shin J, Swift J, Spinler K, Discher D (2011) Myosin-II inhibition and soft 2D matrix maximize multinucleation and cellular projections typical of platelet-producing megakaryocytes. Proc Natl Acad Sci USA 108:11458–11463
Slichter S (2006) Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients. J Clin Apher 21:78–84
Takayama N, Nishimura S, Nakamura S, Shimizu T, Ohnishi R, Endo H, Yamaguchi T, Otsu M, Nishimura K, Nakanishi M, Sawaguchi A, Nagai R, Takahashi K, Yamanaka S, Nakauchi H, Eto K (2010) Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. J Exp Med 207:2817–2830
Takeuchi K, Ogura M, Saito H, Satoh M, Takeuchi M (1991) Production of platelet-like particles by a human megakaryoblastic leukemia cell line (MEG-01). Exp Cell Res 193:223–226
Tavassoli M (1980) Megakaryocyte-platelet axis and the process of platelet formation and release. Blood 55:537–545
Teramura M, Kobayashi S, Hoshino S, Oshimi K, Mizoguchi H (1992) Interleukin-11 enhances human megakaryopoiesis in vitro. Blood 79:327–331
Unger C, Skottman H, Blomberg P, Dilber M, Hovatta O (2008) Good manufacturing practice and clinical-grade human embryonic stem cell lines. Hum Mol Genet 17:R48–R53
van den Oudenrijn S, de Haas M, Calafat J, van der Schoot C, von dem Borne A (1999) A combination of megakaryocyte growth and development factor and interleukin-1 is sufficient to culture large numbers of megakaryocytic progenitors and megakaryocytes for transfusion purposes. Br J Haematol 106:553–563
van den Oudenrijn S, von dem Borne A, de Haas M (2000) Differences in megakaryocyte expansion potential between CD34+ stem cells derived from cord blood, peripheral blood, and bone marrow from adults and children. Exp Hematol 28:1054–1061
Acknowledgments
This study was supported by Grant-in-Aids for Scientific Researches, No. 25289295, from the Ministry of Education, Culture, Sports, Science and Technology of Japan.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Nurhayati, R.W., Ojima, Y. & Taya, M. Recent developments in ex vivo platelet production. Cytotechnology 68, 2211–2221 (2016). https://doi.org/10.1007/s10616-016-9963-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10616-016-9963-4